Minimum Lot Size
Issue Open Date
Issue Close Date
Gujarart-based ISO 9001:2015 and 14001:2015 certified company has a history of more than two decades in the chemical industry. Chemcon speciality chemicals are the sole producer of HMDS (Hexamethyldisilazane) and CMIC which are used in pharmaceutical industry predominantly. The company is the third largest manufacturer of HMDS and second largest manufacturer of CMIC in the world. The product portfolio of the company is not limited to pharmaceutical industry but has strong footprints in the oilfield segment. The company produces Calcium Bromide, Zinc Bromide and Sodium Bromide which are used as completion fluids in the oilfields. The company also undertakes contract manufacturing projects for chemical custom manufacturing.
|S.No.||1 - Company||2 - Directors||3 - Promoters|
|Entity Name||By the Company||Against the Company||By the Director||Against the Director||By the Promoter||Against the Promoter|
|Material civil cases||-||-||-||-||-||-|
|Regulatory Procedings||-||-||-||Not Quantifiable||-||Not Quantifiable|
|Amt. (In Million Rs.)||-||2.69||-||-||-||-|
|Gross Operating Income||2660.17||3053.26||1583.91|
|Cost of Employee & Inventory||1629.57||2090.28||966.05|
|Profit Before Tax||649.23||612.03||405.51|
|Profit After Tax||488.53||430.41||263.81|
The promoters of the company are KamalKumar Rajendra Aggarwal, Navdeep Naresh Goyal, and Shubharangana Goyal.
In the listed space, the company has number of competitors such as Vinati Organics, Aarti Industries, Sudarshan Chemical Industries, Fine Organic Industries, Atul, Paushak and Neogen Chemicals. However, the product mix of the company and their global coverage makes it a major player in the oligopolistic market structure.
The object of the Offer for Sale is to allow the shareholders to sell an aggregate of up to 4,500,000 Equity Shares held by them. The company will not receive any proceeds from the Offer for Sale. Offer for Sale Size is of 4,500,000 Equity Shares having ₹10 aggregating up to Rs.153 Cr at the upper price band of Rs. 340.
The company has planned to raise fresh capital comprising an aggregate of 4,852,950 shares having ₹10 aggregating up to Rs. 165 Cr at the upper price band of Rs. 340. The net proceeds from the issue will be utilized for meeting capital expenditures which is required to expand their manufacturing facility in which total expenditure is expected at Rs. 41.03 crores. The net proceeds will be further utilized for taking care of working capital requirements amounting at Rs. 90 crores while rest will be utilized for other corporate purposes.